Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HESTER BIOSCIENCES vs BETA DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    HESTER BIOSCIENCES BETA DRUGS HESTER BIOSCIENCES/
BETA DRUGS
 
P/E (TTM) x 88.8 - - View Chart
P/BV x 6.9 12.8 54.4% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 HESTER BIOSCIENCES   BETA DRUGS
EQUITY SHARE DATA
    HESTER BIOSCIENCES
Mar-24
BETA DRUGS
Mar-24
HESTER BIOSCIENCES/
BETA DRUGS
5-Yr Chart
Click to enlarge
High Rs1,9281,595 120.9%   
Low Rs1,293645 200.6%   
Sales per share (Unadj.) Rs357.9307.7 116.3%  
Earnings per share (Unadj.) Rs24.937.9 65.6%  
Cash flow per share (Unadj.) Rs45.148.1 93.7%  
Dividends per share (Unadj.) Rs6.000-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs342.9163.5 209.7%  
Shares outstanding (eoy) m8.519.61 88.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.53.6 123.6%   
Avg P/E ratio x64.729.5 219.1%  
P/CF ratio (eoy) x35.723.3 153.4%  
Price / Book Value ratio x4.76.9 68.5%  
Dividend payout %24.10-   
Avg Mkt Cap Rs m13,70210,765 127.3%   
No. of employees `000NANA-   
Total wages/salary Rs m641201 318.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,0452,957 103.0%  
Other income Rs m11114 771.2%   
Total revenues Rs m3,1572,972 106.2%   
Gross profit Rs m578599 96.4%  
Depreciation Rs m17298 175.6%   
Interest Rs m19828 701.2%   
Profit before tax Rs m320488 65.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m108123 87.6%   
Profit after tax Rs m212364 58.1%  
Gross profit margin %19.020.3 93.6%  
Effective tax rate %33.825.3 133.6%   
Net profit margin %7.012.3 56.4%  
BALANCE SHEET DATA
Current assets Rs m2,1461,876 114.4%   
Current liabilities Rs m1,058944 112.1%   
Net working cap to sales %35.731.5 113.4%  
Current ratio x2.02.0 102.1%  
Inventory Days Days4313 343.8%  
Debtors Days Days94978 9.6%  
Net fixed assets Rs m4,477748 598.4%   
Share capital Rs m8596 88.5%   
"Free" reserves Rs m2,8331,475 192.1%   
Net worth Rs m2,9181,571 185.7%   
Long term debt Rs m1,81860 3,009.0%   
Total assets Rs m6,6232,624 252.4%  
Interest coverage x2.618.3 14.3%   
Debt to equity ratio x0.60 1,620.2%  
Sales to assets ratio x0.51.1 40.8%   
Return on assets %6.215.0 41.3%  
Return on equity %7.323.2 31.3%  
Return on capital %10.931.6 34.6%  
Exports to sales %12.815.0 85.2%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs m390445 87.7%   
Imports (cif) Rs mNA10 0.0%   
Fx inflow Rs m390445 87.7%   
Fx outflow Rs m2241 52.4%   
Net fx Rs m369404 91.3%   
CASH FLOW
From Operations Rs m481309 155.6%  
From Investments Rs m-227-140 162.1%  
From Financial Activity Rs m-260-75 347.7%  
Net Cashflow Rs m-495 -4.3%  

Share Holding

Indian Promoters % 44.3 66.7 66.4%  
Foreign collaborators % 9.5 0.0 -  
Indian inst/Mut Fund % 0.6 1.3 46.9%  
FIIs % 0.6 1.2 53.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 46.3 33.3 139.1%  
Shareholders   11,538 2,567 449.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare HESTER BIOSCIENCES With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on HESTER PHARM vs BETA DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

HESTER PHARM vs BETA DRUGS Share Price Performance

Period HESTER PHARM BETA DRUGS S&P BSE HEALTHCARE
1-Day 0.06% 5.14% 1.23%
1-Month 3.70% 5.14% -0.24%
1-Year 55.10% 5.14% 43.62%
3-Year CAGR 1.85% 1.68% 20.35%
5-Year CAGR 8.26% 1.01% 26.24%

* Compound Annual Growth Rate

Here are more details on the HESTER PHARM share price and the BETA DRUGS share price.

Moving on to shareholding structures...

The promoters of HESTER PHARM hold a 53.7% stake in the company. In case of BETA DRUGS the stake stands at 66.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of HESTER PHARM and the shareholding pattern of BETA DRUGS .

Finally, a word on dividends...

In the most recent financial year, HESTER PHARM paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 24.1%.

BETA DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of HESTER PHARM, and the dividend history of BETA DRUGS .

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.